Papachristou Georgios I, Papachristou Dionysios J, Avula Haritha, Slivka Adam, Whitcomb David C
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Pancreatology. 2006;6(4):279-85. doi: 10.1159/000092689. Epub 2006 Apr 19.
Obese patients appear to be at risk for complications of acute pancreatitis (AP). APACHE-O score has been suggested to improve APACHE-II accuracy in predicting severe outcome in AP.
To determine if APACHE-O adds any predictive value to APACHE-II score and to test the hypothesis that obese patients are at increased risk of severe AP (SAP) because of a more intense inflammatory response to pancreatic injury.
102 AP patients were prospectively studied. Using a body mass index (BMI) >30, 28% of the subjects were obese. Nineteen patients developed organ dysfunction and were classified as SAP. Receiver-operating curves for prediction of SAP were calculated using admission APACHE-II and APACHE-O scores. Binary logistic regression was performed to assess if obesity is a risk for SAP and to determine the clinical factors associated with severe disease. Serum levels of IL-6, MCP-1 and CRP as well as Ranson's scores were compared between obese and non-obese patients.
Admission APACHE-O (area under the curve AUC 0.895) and APACHE-II (AUC 0.893) showed similar accuracy in predicting severe outcome. BMI was identified as a significant risk for SAP (OR 2.8, p = 0.048) and mortality (OR 11.2, p = 0.022). CRP levels were significantly higher in obese AP patients (p = 0.0001) as well as Ranson's score (p = 0.021). IL-6 and MCP-1 levels were higher in obese patients but did not reach statistical significance.
Obesity is an independent risk for SAP. Admission APACHE-O score is not more accurate than APACHE-II. Our study results suggest that obesity increases the severity of AP by amplifying the immune response to injury.
肥胖患者似乎有发生急性胰腺炎(AP)并发症的风险。有人提出APACHE-O评分可提高APACHE-II在预测AP严重结局方面的准确性。
确定APACHE-O评分是否能为APACHE-II评分增加预测价值,并检验肥胖患者因对胰腺损伤的炎症反应更强烈而发生重症急性胰腺炎(SAP)风险增加这一假设。
对102例AP患者进行前瞻性研究。根据体重指数(BMI)>30,28%的受试者为肥胖。19例患者出现器官功能障碍,被归类为SAP。使用入院时的APACHE-II和APACHE-O评分计算预测SAP的受试者工作曲线。进行二元逻辑回归以评估肥胖是否为SAP的风险因素,并确定与重症疾病相关的临床因素。比较肥胖和非肥胖患者的血清白细胞介素-6(IL-6)、单核细胞趋化蛋白-1(MCP-1)和C反应蛋白(CRP)水平以及兰森评分。
入院时APACHE-O(曲线下面积AUC 0.895)和APACHE-II(AUC 0.893)在预测严重结局方面显示出相似的准确性。BMI被确定为SAP的显著风险因素(比值比OR 2.8,p = 0.048)和死亡率的风险因素(OR 11.2,p = 0.022)。肥胖AP患者的CRP水平显著更高(p = 0.0001)以及兰森评分也更高(p = 0.021)。肥胖患者的IL-6和MCP-1水平更高,但未达到统计学意义。
肥胖是SAP的独立风险因素。入院时APACHE-O评分并不比APACHE-II更准确。我们的研究结果表明,肥胖通过放大对损伤的免疫反应增加了AP的严重程度。